(B) | 1. |
ºC©Ê°©Åè¼W´Þ©Ê¯g (chronic myeloproliferative disease)¡A±`¥iÂǥѥզå²yÆP©ÊÁC»ÄÆQúC¤§¬¡©Ê (LAP activity) Ų§O¶EÂ_¡C¤U¦C¨º¤@¯e¯f¡ALAP°§C¡H
|
A. | ¯u©Ê¦h¦å¯g (polycythemia vera rubra) |
B. | ºC©Ê°©Åè©Ê¥Õ¦å¯g (chronic myelogenous leukemia) |
C. | ìµo©Ê¦å¤pªO¼W¦h¯g (primary thrombocytosis) |
D. | ìµo©Ê°©ÅèÅÖºû¯g (primary myelofibrosis) |
E. | °©Åèµw¤Æ¯g (myelosclerosis) |
|
(D) | 2. |
¦³Ãö´c©Ê²O¤Ú½F¡A¤U¦C¨º¤@¶µ±Ôz¬O¿ù»~¡H
|
A. | ´c©Ê²O¤Ú½Fªºµo¥Íì¦]»P¯f¬r·P¬V¦³±K¤ÁÃö«Y¡A¤w³QÃҹ꦳Ãöªº¯f¬r¦³ EB ¯f¬r©MHTLV ²Ä¤@«¬ |
B. | «ÕªùÁ³±Û±ìµß (Helicobacter pylori) ¥i¾ÉPG¤§²O¤Ú½F gastric MALT lymphoma (MALToma) |
C. | Bcl-2 °ò¦]²£ª«¡A¥i§í¨îÀù²ÓMä¤` (apoptosis)¡A¾ÉP²O¤Ú½F |
D. | T-²ÓM©Ê²O¤Ú½F¡A¸û¤Ö«I¥Ç²O¤Úµ²¥~¤§²Õ´©Î¾¹©x (extra-nodal involvement) |
E. | ¥xÆWªº´c©Ê²O¤Ú½F¡A¬ù 90% ¬°«D»®ªNª÷¤ó²O¤Ú½F¡A10% ¬°Hodgkin's lymphoma |
|
(D) | 3. |
¦³ÃöºKµÊ (splenectomy)¡A¤U¦C¨º¤@¶µ±Ôz¬O¿ù»~ªº¡H
|
A. | ¥Î©óªvÀø¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g (congenital spherocytosis) |
B. | ¥Î©óªvÀøµÊ¤®¶i (hypersplenism) ©Ò¾ÉP¤§¦å²y´î¤Ö¯g (cytopenia) |
C. | ¥Î©óªvÀø¾vª¬²ÓM©Ê¥Õ¦å¯g (hairy cell leukemia) |
D. | ºKµÊ«á¡A±`¨£WBC ¼Æ¼W¥[¡A¦ý¬õ¦å²y§ÎºA«h¨S¦³ÅÜ¤Æ |
E. | 20 ·³¥H¤U±wªÌ¡AºKµÊ«á¡A¸û©ö¦³ÄY«²Óµß·P¬V |
|
(C) | 4. |
¦³Ãö M-GUS (Monoclonal Gammopathies of Uncertain Significance)¡A¤U¦C¨º¤@¶µ±Ôz¬O¥¿½Tªº¡H
|
A. | ¦å²M¤¤¦³ M-protein¡A±`¶W¹L 3 gm/dl |
B. | °©Å褤¼ß²ÓM (plasma cell) ¶W¹L 10% |
C. | §¿¤¤¨S¦³ Bence-Jones protein |
D. | ±`¦³°©Àf¤§·»°©ªº¯f¨_ (osteolytic lesions) |
E. | ·U¦´Á°µ¤Æ¾ÇªvÀø·U¦n |
|
(B) | 5. |
¬Y¨k©Ê 50 ·³¡AÅç¦åµ²ªG¦p¤U¡G RBC:3.0 M/£gl, Hb:9 g/dl, Hct.:30%, WBC:5000/£gl, Platelet:150 k /£gl, reticulocyte:3.0%¡A¥Õ¦å²y¤ÀÃþµL²§±`¡C½Ð°Ý¨ä¶EÂ_¡A¥H¤U¦C¨º¤@ºØªº¥i¯à©Ê³Ì¤j¡H
|
A. | ¦A¥Í¤£¨}©Ê³h¦å (aplastic anemia) |
B. | «æ©Ê¥X¦å©Ê³h¦å (acute blood loss) |
C. | ¯ÊÅK©Ê³h¦å (iron deficiency anemia) |
D. | £\«¬®ü¬v©Ê³h¦å (£\-thalassemia)) |
E. | ¸»Ä¤í¯Ê©Ê³h¦å (folate deficiency anemia) |
|
(E) | 6. |
Yn¶EÂ_¦´Á¯ÊÅK²{¶H (early iron deficiency)¡A°µ¤U¦C¨º¤@¶µÀˬd¡A³Ì¬°½T¹ê¦Ó¦³·N¸q¡H
|
A. | Hb Ȥ§´ú¸Õ |
B. | ¬õ¦å²y§ÎºA¤§Æ[¹î |
C. | ¦å²M¬õ¦å²y¥Íªø¿E¯À (erythropoietin) ¤§©w¶q |
D. | ¦å²MÅK (serum iron) ¤§©w¶q |
E. | ¦å²MÅK³J¥Õ (serum ferritin) ¤§©w¶q |
|
(C) | 7. |
¤U¦C¯e¯f¡A§¡·|¤Þ°_·»¦å©Ê³h¦å¡A¨º¤@¶µ¤£ÄÝ©ó¦åºÞ¤º¤§·»¦å (intravascular hemolysis)¡H
|
A. | ABO ¦å«¬¤£¦X¤Þ°_¤§·»¦å (ABO mismatched transfusion) |
B. | °}µo©Ê©]¶¡©Ê¦å¬õ¯À§¿¯g (paroxysmal nocturnal hemoglobinuria) |
C. | ¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g (hereditary spherocytosis) |
D. | G6PD ¤í¯Ê¯g (G6PD deficiency) |
E. | ¤ßŦ佤¤§¸m´«¤â³N«á (valve replacement) |
|
(A) | 8. |
¤U¦C±Ôz¡A¦óªÌ¬O¿ù»~ªº¡H
|
A. | ¦~»´¤H¡AY¤ÏÂеo¥ÍÀR¯ß¦å®ê¯g (venous thrombosis) À³¦Ò¼{AT III (antithrombin III) ¼W¥[²{¶H |
B. | Âಾ©ÊÀù¯g¡A¥iµo¥ÍÀR¯ß¦å®ê¯g¡A¤×¨ä¬O¸¢Àù |
C. | ìµo©Ê¦å¤pªO¼W¦h¯g (primary thrombocytosis) ©ö¾ÉP¦å®ê¯g |
D. | Lupus-like anticoagulant ¥i¾ÉPÀR¯ß¦å®ê¯g¡A¥ç¥i¤Þ°_¥X¦å²{¶H |
E. | ¿éª`¤j¶q®w¦s¦å (stored blood) ±N¥i¤Þ°_¥X¦å²{¶H |
|
(B) | 9. |
¤U¦C±Ôz¡M¨º¤@¶µ¬O¤£¥¿½Tªº¡H
|
A. | ¥¿±`¤H¦å¤¤¦³ vWF (von Willebrand factor) 10 mg/L |
B. | ÄY«©Ê¥Ò«¬¦å¤Í¯f±wªÌ¨ä PT ¤Î PTT §¡©µªø |
C. | ¥¿±`¤§¤î¦å¤Î¾®¦å¹Lµ{¡A»Ý¦å¤¤³Ì¤Ö¦³²Ä¤K¾®¦å¦]¤l 25% ¥H¤W |
D. | ¦å¤¤²Ä¤K¾®¦å¦]¤l¤§¥b°I´Á¡A¶È¦³ 8~10 ¤p®É |
E. | ·í¨xŦ¹ê½è¯fÅÜ (parenchymal disorder)¡A²Ä¤@Ó´î¤Öªº¦å²G¾®©T¦]¤l¬°²Ä¤C¦]¤l |
|
(D) | 10. |
«æ©Ê¥Õ¦å¯f¡A¨ã¦³¤U¦C¨º¤@ºØ¬V¦âÅ骺ÅܤơA¹w«á¸û¦n¡H
(µù¡GAML:«æ©Ê°©Åè©Ê¥Õ¦å¯f¡MALL:«æ©Ê²O¤Ú©Ê¥Õ¦å¯f)
(1) ALL t(9,22)¡M(2) ALL t(8,14)¡M(3) AML t(9,22)¡M(4) AML t(15,17)
|
A. | 1, 2, 3 |
B. | 1, 3 |
C. | 2, 4 |
D. | 4 |
E. | 1, 2, 3, 4 |
|